Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionNewEdge Wealth, LLC
Latest Disclosed Ownership706,725 shares
Latest Disclosed Value $ 98,496,202
NewEdge Wealth, LLC reports 9.32% increase in ownership of GILD / Gilead Sciences, Inc.

On May 13, 2026 - NewEdge Wealth, LLC filed a 13F-HR form disclosing ownership of 706,725 shares of Gilead Sciences, Inc. (CH:GILD) valued at $98,496,202 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 3, 2026 disclosing 646,470 shares of Gilead Sciences, Inc.. This represents a change in shares of 9.32% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F GILEAD SCIENCES COM 375558103 706,725 60,255 9.32 98,496 24.13 1.1732
2026-02-03 2025-12-31 13F GILEAD SCIENCES COM 375558103 646,470 26,780 4.32 79,348 4.46 0.8964
2025-11-07 2025-09-30 13F GILEAD SCIENCES COM 375558103 619,690 17,284 2.87 75,962 14.34 1.0890
2025-08-11 2025-06-30 13F GILEAD SCIENCES COM 375558103 602,406 170,165 39.37 66,433 37.17 1.0406
2025-05-09 2025-03-31 13F GILEAD SCIENCES COM 375558103 432,241 27,424 6.77 48,433 29.53 0.8772
2025-02-05 2024-12-31 13F GILEAD SCIENCES COM 375558103 404,817 30,243 8.07 37,393 19.07 0.6485
2024-11-12 2024-09-30 13F GILEAD SCIENCES COM 375558103 374,574 4,087 1.10 31,404 23.55 0.5667
2024-08-02 2024-06-30 13F GILEAD SCIENCES COM 375558103 370,487 -6,943 -1.84 25,419 3.09 0.5506
2024-05-06 2024-03-31 13F GILEAD SCIENCES COM 375558103 377,430 37,463 11.02 24,658 -10.47 0.5531
2024-01-29 2023-12-31 13F GILEAD SCIENCES COM 375558103 339,967 27,572 8.83 27,541 17.64 0.7039
2023-11-08 2023-09-30 13F GILEAD SCIENCES COM 375558103 312,395 47,137 17.77 23,411 14.51 0.7418
2023-08-09 2023-06-30 13F GILEAD SCIENCES COM 375558103 265,258 81,231 44.14 20,443 33.89 0.6829
2023-05-08 2023-03-31 13F GILEAD SCIENCES COM 375558103 184,027 97,736 113.26 15,269 106.10 0.5795
2023-02-14 2022-12-31 13F GILEAD SCIENCES COM 375558103 86,291 3,874 4.70 7,408 45.71 0.3190
2022-11-14 2022-09-30 13F GILEAD SCIENCES COM 375558103 82,417 -23,415 -22.12 5,084 -22.27 0.2404
2022-08-09 2022-06-30 13F GILEAD SCIENCES COM 375558103 105,832 33,126 45.56 6,541 51.34 0.2971
2022-05-10 2022-03-31 13F GILEAD SCIENCES COM 375558103 72,706 6,129 9.21 4,322 -10.59 0.1919
2022-01-31 2021-12-31 13F GILEAD SCIENCES COM 375558103 66,577 5,011 8.14 4,834 12.42 0.2026
2021-11-12 2021-09-30 13F GILEAD SCIENCES COM 375558103 61,566 61,566 4,300 0.2559
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.